Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers
Open Access
- 15 June 2020
- Vol. 12 (6), 1578
- https://doi.org/10.3390/cancers12061578
Abstract
Conflicting results have been reported regarding the prevalence of screen-detected human epidermal growth factor receptor 2 (HER2)-positive breast carcinomas and non-screen detected HER2-positive breast carcinomas. To address this issue, we evaluated the prevalence of HER2-positive breast carcinomas in two independent regional screening programs in Spain. The clinicopathologic and immunohistochemical characteristics of 479 (306 and 173) screen-detected breast carcinomas and 819 (479 and 340) non-screen-detected breast carcinomas diagnosed in women between 50 and 69-year-olds were compared. The prevalence of HER2-positive breast carcinomas was 8.8% and 6.4% in the two series of screen-detected tumors, compared with 16.4% and 13% in non-screen-detected carcinomas. These differences were statistically significant. This lower prevalence of HER2-positive in-screen-detected breast carcinomas was observed in both hormone receptor positive (luminal HER2) and hormone-receptor-negative (HER2 enriched) tumors. In addition, a lower prevalence of triple-negative and a higher prevalence of luminal-A breast carcinomas was observed in screen-detected tumors. Moreover, a literature review pointed out important differences in subrogate molecular types in screen-detected breast carcinomas among reported series, mainly due to study design, technical issues and racial differences.Keywords
Funding Information
- Instituto de Salud Carlos III (PI 19/01331)
This publication has 25 references indexed in Scilit:
- Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 DecadesJAMA Oncology, 2017
- St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-upBritish Journal of Surgery, 2016
- Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical seriesBMC Cancer, 2013
- Aggressiveness features and outcomes of true interval cancersEuropean Journal Of Cancer Prevention, 2013
- Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50–69European Journal Of Cancer Prevention, 2012
- Prognosis and pathology of screen‐detected carcinomasCancer, 2010
- Early Detection of Breast Cancer through Population-Based Mammographic Screening in Asian Women: A Comparison Study between Screen-Detected and Symptomatic Breast CancersThe Breast Journal, 2009
- Prognosis of screen-detected breast cancers: results of a population based studyBMC Cancer, 2006
- Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour sizeBritish Journal of Cancer, 2004
- Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancerThe Breast, 2004